Xie Mingqi, Fussenegger Martin
Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Faculty of Life Science, University of Basel, Basel, Switzerland.
Biotechnol J. 2015 Jul;10(7):1005-18. doi: 10.1002/biot.201400642. Epub 2015 May 26.
Biotechnology is a widely interdisciplinary field focusing on the use of living cells or organisms to solve established problems in medicine, food production and agriculture. Synthetic biology, the science of engineering complex biological systems that do not exist in nature, continues to provide the biotechnology industry with tools, technologies and intellectual property leading to improved cellular performance. One key aspect of synthetic biology is the engineering of deliberately reprogrammed designer cells whose behavior can be controlled over time and space. This review discusses the most commonly used techniques to engineer mammalian designer cells; while control elements acting on the transcriptional and translational levels of target gene expression determine the kinetic and dynamic profiles, coupling them to a variety of extracellular stimuli permits their remote control with user-defined trigger signals. Designer mammalian cells with novel or improved biological functions not only directly improve the production efficiency during biopharmaceutical manufacturing but also open the door for cell-based treatment strategies in molecular and translational medicine. In the future, the rational combination of multiple sets of designer cells could permit the construction and regulation of higher-order systems with increased complexity, thereby enabling the molecular reprogramming of tissues, organisms or even populations with highest precision.
生物技术是一个广泛的跨学科领域,专注于利用活细胞或生物体来解决医学、食品生产和农业中已有的问题。合成生物学,即设计自然界中不存在的复杂生物系统的科学,继续为生物技术产业提供工具、技术和知识产权,从而改善细胞性能。合成生物学的一个关键方面是对经过刻意重新编程的定制细胞进行工程改造,其行为可以在时间和空间上得到控制。本综述讨论了工程化哺乳动物定制细胞最常用的技术;虽然作用于靶基因表达转录和翻译水平的控制元件决定了动力学和动态特征,但将它们与各种细胞外刺激耦合可以通过用户定义的触发信号对其进行远程控制。具有新颖或改进生物学功能的定制哺乳动物细胞不仅直接提高了生物制药生产过程中的生产效率,也为分子和转化医学中基于细胞的治疗策略打开了大门。未来,多组定制细胞的合理组合可以构建和调控具有更高复杂性的高阶系统,从而实现对组织、生物体甚至群体的分子重编程,达到最高精度。